CLINUVEL starts SCENESSE supply into China
- CLINUVEL and Winhealth sign Collaboration Agreement to serve Chinese EPP population
- CLINUVEL remains responsible for clinical care and pharmacovigilance, Winhealth in charge of hospital management
- Named Patient Program (NPP) initiated to supply SCENESSE® to 10 Chinese EPP patients
- Local Chinese subsidies in place for EPP patients
- NPP data, FDA and EMA submissioncount towards NMPA (Chinese regulatory authority) submission.
http://www.clinuvel.com/clinuvel-starts-scenesse-supply-into-china-2
http://en.winhealth.hk/
http://www.clinuvel.com/investors-area/news-2/media-release-scenesse-to-be-prescribed-in-china
- Forums
- ASX - By Stock
- News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment
CLINUVEL starts SCENESSE supply into China- CLINUVEL and...
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.37 |
Change
0.130(0.85%) |
Mkt cap ! $770.0M |
Open | High | Low | Value | Volume |
$15.36 | $15.54 | $15.18 | $1.274M | 82.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 237 | $15.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.50 | 282 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 15.200 |
1 | 100 | 15.170 |
1 | 989 | 15.120 |
1 | 2000 | 15.020 |
1 | 2 | 15.000 |
Price($) | Vol. | No. |
---|---|---|
15.780 | 500 | 1 |
15.850 | 1000 | 1 |
15.860 | 193 | 1 |
15.880 | 500 | 1 |
15.900 | 500 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online